Zymeworks Signs Roche Deal with $55 Million Upfront, Up to $718 Million in Milestones
Zymeworks (ZYME) said Friday it signed an exclusive global license and collaboration agreement with
Keep reading this article with Yahoo Finance Plus Silver
Silver
- Premium news Full access to Financial Times and MT Newswires articles
- Stock picks Expert picks from Motley Fool, Zacks, and Moby
- Research reports Expert analysis from Morningstar and Argus
